| Registered Number:08977342 |
For the period ended 31 January 2025
England and Wales
Unaudited Financial Statements
For the period ended 31 January 2025
FK Pharma Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
FK Pharma Limited
Statement of Financial Position
2024
2025
750,000
750,000
2
750,000
750,000
| Trade and other receivables |
-
55,000
3
8
| Cash and cash equivalents |
8
55,008
8
| Trade and other payables: amounts falling due within one |
| year |
(28,051)
(23,464)
4
(28,043)
31,544
Net current assets
| Total assets less current liabilities |
781,544
721,957
| Trade and other payables: amounts falling due after more |
| than one year |
(694,639)
(658,669)
5
122,875
Net assets
27,318
1
1
122,874
27,317
122,875
27,318
Shareholders' funds
| For the period ended 31 January 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006 |
| The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| Faiz Mujadad Khan Director |
| These financial statements were approved and authorised for issue by the Board on 29 October 2025 and were signed by: |
| The notes form part of these financial statements |
1 of 3
For the period ended 31 January 2025
FK Pharma Limited
Notes to the Financial Statements
Statutory Information
| FK Pharma Limited is a private limited company, limited by shares, domiciled in England and Wales, registration |
| number 08977342. |
8 Woodhall Close
Bolton
Lancashire
BL2 3AZ
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
| Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the |
| Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
| modified by the revaluation of certain assets. |
Revenue recognition
| Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. |
| 2. Investments held as fixed assets |
750,000
750,000
750,000
750,000
750,000
750,000
750,000
750,000
| 3. Trade and other receivables |
2024
2025
55,000
-
2 of 3
For the period ended 31 January 2025
FK Pharma Limited
Notes to the Financial Statements Continued
| 4. Trade and other payables: amounts falling due within one year |
2024
2025
| Bank loans and overdraft (secured) |
21,500
26,827
408
576
| Taxation and social security |
224
-
1,332
648
23,464
28,051
| 5. Trade and other payables: amounts falling due after more than one year |
2024
2025
| Bank loans and overdraft (secured) |
557,321
571,157
101,348
123,482
658,669
694,639
| 6. Average number of persons employed |
During the year the average number of employees was 0
3 of 3